Tempsens Instruments (India) IPO is in the final day of subscription on August 24 with extremely high interest from investors and the GMP (grey market premium) is up to triple digits. As of the latest available grey market data cited by IPO trackers, the GMP is around ₹313 per share which is a premium of about 104.33% over the upper IPO price of ₹300.
The strong GMP has placed Tempsens Instruments among the most closely watched IPOs in the Indian primary market. But GMP is an unofficial indicator and does not guarantee the actual listing price. Investors should therefore look beyond the grey market to assess the issue.
The IPO has a price band of ₹285–₹300 per share and a lot size of 50 shares. A retail investor applying for one lot at the top of the price band would need ₹15,000. This issue comprises a fresh issue of ₹95 crore and an offer for sale of ₹555 crore.
GMP Signals Strong Listing Expectations
At GMP of ₹313 against the ₹300 upper issue price, the implied grey-market price is about ₹613 per share. So that implies a listing premium of around 104.33% if GMP were to fully translate into the listing price.
For a 50-share lot, the difference between the issue price and the GMP-implied price would be about ₹15,650. However, this is only a theoretical calculation based on unofficial grey-market pricing and should not be treated as an assured return.
The GMP has strengthened considerably during the IPO period. Previous reports showed the premium at much lower levels before it moved above ₹300. The GMP had crossed 100% by the last day, Economic Times reported, reflecting extremely strong market expectations around the issue.
Subscription Demand Adds to the Buzz
The strong grey market premium has been accompanied by high subscription demand. By 10:15 am on the last day the issue had already been subscribed more than 28 times by NSE data reported by Moneycontrol.
The IPO had already attracted a lot of interest in the first two days. At the end of Day 2 it was subscribed more than 21 times, showing the strong appetite of investors.
What Does Tempsens Instruments Do?
Tempsens Instruments is a Rajasthan-based company that provides temperature measurement and control solutions. Solutions for temperature sensors, electrical heating solutions, specialised cables and related industrial products are available for these products.
The company has a huge presence in specialised temperature-sensing products and operates in domestic and international markets. About 29% of its sales are generated from exports and the majority of metals and petrochemical customers are part of the business.
Investor interest is also attracted by the niche positioning of the company. The company has also been called India’s only manufacturer of fibre-optic temperature sensors and has the unique position within its industry.
Valuation and Risks
The strong GMP must not be taken in isolation. At the highest issue price of ₹300, IPO data indicates that a post-issue P/E multiple of around 35.38 times is to be expected, and valuation is a key factor for investors looking for long-term returns.
And of course the company faces risks that investors ought to be aware of. Its working-capital cycle is still significant and relatively low capacity utilisation and reliance on large project orders could cause future growth and cash flow problems. Customer concentration is also a risk to consider since more than 40% of revenue is reported to be coming from metal and petrochemical companies.
The IPO proceeds themselves are fairly modest in terms of fresh capital as most of the IPO is an OFS issue. Of the ₹650 crore issue, ₹555 crore is offered through the offer-for-sale part and ₹95 crore fresh issuance. A portion of the new funds is intended for capital expenditure and repayment or prepayment of borrowings.
Application Decision
With the IPO closing today, the combination of a ₹313 GMP, strong subscription demand and the company's specialised business profile has created a very bullish short-term narrative around Tempsens Instruments.
The investors who choose to apply should know that the decision is based on risk tolerance, valuation, business fundamentals and investment objectives -- not GMP alone. Grey market premiums can change quickly before listing and are not an official exchange-based indicator.
The IPO is scheduled to close on 24 August, with the IPO allotment on 25 August and shares to list on 28 August, according to available timing of the IPO.
For both the investors who participate, the main question now is whether the huge GMP will translate to a strong stock market debut as well. The current grey-market signals are pointing to huge listing upside, but the listing price will ultimately be a function of market conditions and investor demand on the day of the listing.
This article is for informational purposes only and does not constitute any investment advice or recommendation for investors to apply for an IPO. GMP is unofficial, can change rapidly and may not be an accurate prediction of the actual listing price. Investors should conduct their own detailed research and consult a financial adviser before making an investment decision.
Comments
Please to leave a comment on this article.